دارو جابرابن حیان
دجابر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 57,940 3.00
Close Price: 57,940
Cash Flow
AGM
Interim
2026/02/23 Fiscal Year 2025/12/2112 Month / Audited | 2026/01/28 Fiscal Year 2025/12/2112 Month | ||
|---|---|---|---|
Cash Generated from Operations | -1.357 Trillion | -1.767 Trillion | |
Income Taxes Paid | -137.93 Billion | -103.198 Billion | |
Net Cash Flow from Operating Activities | -1.495 Trillion | -1.871 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 8.972 Billion | - | |
Purchases of Property, Plant and Equipment | -41.12 Billion | -13.897 Billion | |
Dividends Received | 307.824 Billion | 389.791 Billion | |
Net Cash Flow from Investing Activities | 275.676 Billion | 375.894 Billion | |
Net Cash Flow before Financing Activities | -1.22 Trillion | -1.495 Trillion | |
Cash Received from Borrowings | 4.131 Trillion | 4.131 Trillion | |
Repayments of Borrowings (Principal) | -3.84 Trillion | -3.84 Trillion | |
Interest Paid on Borrowings | -761.166 Billion | -760.191 Billion | |
Dividends Paid | -2.96 Trillion | -2.686 Trillion | |
Net Cash Flow from Financing Activities | -3.431 Trillion | -3.156 Trillion | |
Net Increase (Decrease) in Cash | -4.65 Trillion | -4.65 Trillion | |
Cash at Beginning of Period | 5.134 Trillion | 5.134 Trillion | |
Effect of Exchange Rate Changes | 21.885 Billion | 21.886 Billion | |
Cash at End of Period | 5.156 Trillion | 5.156 Trillion | |
Non-Cash Transactions | 197.4 Billion | - |